| Literature DB >> 30257425 |
Stéphanie Bouillot1, Emeline Reboud2, Philippe Huber3.
Abstract
Bacterial pore-forming toxins induce a rapid and massive increase in cytosolic Ca2+ concentration due to the formation of pores in the plasma membrane and/or activation of Ca2+-channels. As Ca2+ is an essential messenger in cellular signaling, a sustained increase in Ca2+ concentration has dramatic consequences on cellular behavior, eventually leading to cell death. However, host cells have adapted mechanisms to protect against Ca2+ intoxication, such as Ca2+ efflux and membrane repair. The final outcome depends upon the nature and concentration of the toxin and on the cell type. This review highlights the repercussions of Ca2+ overload on the induction of cell death, repair mechanisms, cellular adhesive properties, and the inflammatory response.Entities:
Keywords: bacterial virulence factor; cell death; host–pathogen interaction; ion flux; signal transduction
Mesh:
Substances:
Year: 2018 PMID: 30257425 PMCID: PMC6215193 DOI: 10.3390/toxins10100387
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1Potential Ca2+ circuitry induced by pore-forming toxins (PFTs) and main reported effects of sustained Ca2+ elevation. Increased cytosolic Ca2+ concentrations can be induced by passive flow through the pore and/or activation of Ca2+-channels either in the plasma membrane, in the endoplasmic reticulum (ER) (IP3R, via G-proteins-PLs-IP3 pathway), or in the lysosome (TPC, via CD38-NAADP pathway). Ca2+ pumps in the plasma membrane (PMCA), the ER (SERCA) and the mitochondria (MCU) are employed to maintain low levels of cytosolic Ca2+. Ca2+ binds and activates members of annexin family to promote pore endocytosis, or the ESCRT complex for microvesicle secretion. Ca2+ interacts also with calmodulin, which detaches from pro-ADAM10, allowing its maturation and export to the plasma membrane where it cleaves cadherins. Ca2+ activates a number of proteins, including MLCK, which promotes actomyosin constriction and TJ protein redistribution from the junction. Ca2+ intoxication activates several cell death pathways: (i) necrosis can be induced by osmotic lysis, by activated calmodulin and calpains, by release of cathepsins from lysosomes or ROS from mitochondria; (ii) apoptosis by release of AIF and cytochrome c from mitochondria or by activated calpains and calmodulin; (iii) NLRP3-dependent pyroptosis from mitochondrial signals; and (iv) necroptosis, by activation of RIP1, RIP3, and MLKL. Abbreviations: AIF, apoptosis-inducing factor; ESCRT, endosomal sorting complex required for transport; IP3R, inositol triphosphate receptor; MLCK, myosin light chain-kinase; MCU, mitochondrial Ca2+ uniporter; MLKL, mixed-lineage kinase domain-like protein; NAADP, nicotinic acid adenine dinucleotide phosphate; PKC, protein kinase C; PL, phospholipase; PMCA, plasma membrane Ca2+-ATPase; RIP, receptor interacting protein; ROS, reactive oxygen species; SERCA, sarco/endoplasmic reticulum Ca2+-ATPase; TJ, tight junction; TPC, two-pore channel.
PFTs reported to promote increases in intracellular Ca2+ concentrations.
| Species | Toxin Name 1 | Pore Size 2 | Ca2+ Origin 3 | Ca2+ Kinetics | Reported Effects of PFT-Induced Ca2+ Influx | Refs |
|---|---|---|---|---|---|---|
|
| Ltx | n. d. | EC | Monophasic | ∙ Neutrophil lysis | [ |
|
| Aerolysin | Small | EC + IC | Multiphasic | ∙ Granulocyte chemotaxis | [ |
|
| ASH | Small | EC + IC | Biphasic | [ | |
|
| ACT = CyaA | Small | EC | Multiphasic via non-voltage dependent channels with L-type properties | ∙ Prevents ACT endocytosis and degradation | [ |
|
| PFO | Large | EC | Unknown | ∙ Activates/enhances repair mechanism | [ |
| CPE | Small | Unknown | Biphasic | ∙ Apoptosis and necrosis through calpain and calmodulin-dependent processes | [ | |
| ET | Small | EC | Monophasic | [ | ||
|
| α-toxin | Small | EC | Biphasic | ∙ Necrosis induced by multiple pathways | [ |
|
| HlyA | Small | EC | Oscillations due to Ca2+ channel activation or to rapid formation/closure of the pore | ∙ ROS production by granulocytes | [ |
| ClyA = HlyE | Small | IC | Oscillations | [ | ||
|
| LLO | Large | EC | Oscillation due to rapid formation/closure of the pore and release from IC stores | ∙ Bacterial internalization | [ |
|
| LKT | n. d. | EC through voltage-gated Ca2+ channels | Monophasic | ∙ ROS and leukotriene production by neutrophils | [ |
|
| ExlA | Small | EC | Biphasic | ∙ Cadherin cleavage via ADAM10 activation | [ |
|
| PhlyP | Small | Monophasic | ∙ Lysosomal exocytosis | [ | |
|
| ShlA | Small | EC | Monophasic | ∙ Cadherin cleavage via ADAM10 activation | [ |
|
| Hla = α-toxin | Small | EC | Monophasic | ∙ PLA2 activation | [ |
| Hlg | Small | IC from lysosomes and endoplasmic reticulum | Mono/biphasic | [ | ||
| PVL | Small | As for Hlg | Mono/biphasic | [ | ||
|
| ILY | Large | Unknown | Unknown | ∙ NFAT activation and EGR-1 expression via Ca2+/calcineurin pathway | [ |
|
| PLY | Large | EC | Multiphasic | ∙ Apoptosis | [ |
|
| SLO | Large | EC + IC | Monophasic | ∙ Granulocyte chemotaxis | [ |
1 Ltx, leukotoxin; ASH, A. sobria hemolysin; ACT (or CyaA), adenylate cyclase toxin-hemolysin; PFO, perfringolysin O; CPE, C. perfringens enterotoxin; ET, epsilon toxin; HlyA, hemolysin-α; ClyA (or HlyE), cytolysin A; LLO, lysteriolysin O; LKT, leukotoxin A; ExlA, exolysin A; PhlyP, phobalysin; ShlA, Serratia hemolysin A; HlA, hemolysin-α; Hlg, hemolysin-γ; PVL, Panton–Valentine leukocidin; ILY, intermedilysin; PLY, pneumolysin; SLO, streptolysin O. 2 Internal pore diameter. Small: 1–2 nm; Large: up to 30 nm. n. d., not detrmined. 3 EC, from the extracellular milieu; IC, from intracellular stores; “Ca2+ channels” indicates the activation of cellular Ca2+ channels without or in addition to Ca2+ influx through the PFT.
Cellular death programs triggered by PFT-induced Ca2+ concentration rise.
| Pore-Forming Toxins 1 (Species) | Apoptosis | Necrosis | Necroptosis | Ref. |
|---|---|---|---|---|
| Ltx ( | In T cells. Possibly calpain-dependent | [ | ||
| Aerolysin ( | At low dose in T cells | [ | ||
| CPE ( | At low dose in enterocytes | At high dose in enterocytes | [ | |
| ET ( | In renal collecting duct cells | [ | ||
| α-toxin ( | In myoblasts | [ | ||
| PLY ( | In microglial cells | In pneumocytes | [ | |
| SLO ( | At low dose in keratinocytes | At high dose in keratinocytes | [ | |
| ShlA ( | In pneumocytes | [ |
1 Abbreviations as in Table 1.